STAAR Surgical (STAA) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
STAAR Surgical Reports Second Quarter 2016 Results
August 3, 2016 4:01 PM EDTMONROVIA, Calif., Aug. 3, 2016 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the second quarter ended July 1, 2016.
Second Quarter 2016 Overview
Record Quarterly Net Sales of $21.0 Million Up 12% from the Prior Year Quarter Worldwide ICL Sales Up 26% and Units Up 18% from the Prior Year Quarter Worldwide IOL Sales Down 3% and Units Down 15% from the Prior Year Quarter Gross Margin Improved to 69.7% of... More